Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin doesn't stop hair loss.

Anti-SSB antibodies are useful for diagnosing systemic lupus erythematosus and are linked to specific symptoms.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

More research is needed to understand alopecia areata severity.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Red spots on fingertips can be a sign of a skin condition linked to gluten sensitivity, treatable with a gluten-free diet.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Different skin diseases show unique patterns of skin cell separation, cell death, and granular layer changes.

Cocaine use can cause a blistering skin disease.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Many alopecia patients have undetected thyroid abnormalities that can be found through physical exams.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Scalp involvement in pemphigus means the disease is more severe and harder to treat.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.